GW Pharma to expand in the UK

GW Pharma, one of the marihuana industry’s biggest players, will expand in the UK to meet growing demand for its Sativex drug, according to Marihuana Business Daily on 8/29. Sativex is designated to relieve symptoms of multiple sclerosis, but related forms may also treat epilepsy, cancer, cerebral palsy and schizophrenia (source: Herb). Sativex, whose generic name is nabiximol, is a mouth spray with a 1:1 ratio of THC and CBD. The drug can cause a slight psychoactive effect, but tests show patients do not form a tolerance over one year of use.

The company plans to spend $64 million on this UK expansion in the coming 3 years and hire 90 more workers, bringing its total staff there to about 400. It will cover cultivation and processing. The expansion depends on federal approval of Sativex in the U.S. Sativex is currently available in at least 28 countries by prescription.

GW is based in Cambridge England. It also produces Epidiolex, a CBD-based, anti-seizure medicine, and the first cannabis-based product approved from the U.S. government.

(sources: MBD and Herb)

GW Pharma to expand in the UK

About Cannin: Your Cannabis Stocks Resource

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In

GW Pharma to expand in the UK